Veracyte, Inc. (VCYT)
50.40
+2.20
(+4.56%)
USD |
NASDAQ |
Oct 27, 16:00
50.40
0.00 (0.00%)
After-Hours: 17:01
Veracyte Net Income (Quarterly) : 25.49M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.49M |
| March 31, 2026 | 28.71M |
| December 31, 2025 | 41.15M |
| September 30, 2025 | 19.14M |
| June 30, 2025 | -0.98M |
| March 31, 2025 | 7.047M |
| December 31, 2024 | 5.113M |
| September 30, 2024 | 15.16M |
| June 30, 2024 | 5.734M |
| March 31, 2024 | -1.864M |
| December 31, 2023 | -28.29M |
| September 30, 2023 | -29.62M |
| June 30, 2023 | -8.402M |
| March 31, 2023 | -8.091M |
| December 31, 2022 | -3.844M |
| September 30, 2022 | -8.723M |
| June 30, 2022 | -9.532M |
| March 31, 2022 | -14.46M |
| December 31, 2021 | -10.53M |
| September 30, 2021 | -14.13M |
| June 30, 2021 | -9.038M |
| March 31, 2021 | -41.87M |
| December 31, 2020 | -8.044M |
| September 30, 2020 | -4.124M |
| June 30, 2020 | -11.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.72M |
| December 31, 2019 | -7.458M |
| September 30, 2019 | -0.73M |
| June 30, 2019 | -2.494M |
| March 31, 2019 | -1.917M |
| December 31, 2018 | -3.105M |
| September 30, 2018 | -4.469M |
| June 30, 2018 | -6.248M |
| March 31, 2018 | -9.177M |
| December 31, 2017 | -8.439M |
| September 30, 2017 | -7.049M |
| June 30, 2017 | -7.298M |
| March 31, 2017 | -8.217M |
| December 31, 2016 | -4.403M |
| September 30, 2016 | -5.637M |
| June 30, 2016 | -11.24M |
| March 31, 2016 | -10.08M |
| December 31, 2015 | -8.013M |
| September 30, 2015 | -8.945M |
| June 30, 2015 | -9.136M |
| March 31, 2015 | -7.61M |
| December 31, 2014 | -8.142M |
| September 30, 2014 | -7.902M |
| June 30, 2014 | -6.655M |
| March 31, 2014 | -6.674M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Teleflex, Inc. | 41.76M |
| West Pharmaceutical Services, Inc. | 154.00M |
| Globus Medical, Inc. | 151.57M |
| Illumina, Inc. | 207.00M |
| Inspire Medical Systems, Inc. | 0.314M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 150.32M |
| Total Expenses (Quarterly) | 124.83M |
| EPS Diluted (Quarterly) | 0.3106 |
| Enterprise Value | 3.428B |
| Gross Profit Margin (Quarterly) | 71.93% |
| Profit Margin (Quarterly) | 16.96% |
| Earnings Yield | 2.80% |
| Operating Earnings Yield | 2.37% |
| Normalized Earnings Yield | 2.560 |